Position in VTRS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$8,020,733
+$949,829 QoQ
Shares Held
505,084
-3.5% QoQ
Ownership
0.044%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#139
of 1,016 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CANADA LIFE ASSURANCE Co holds $112,895,525 across 19 Drug Manufacturers - Specialty & Generic names. VTRS ranks #5 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
378,539 | $27,201,812 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
39,673 | $21,496,021 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
608,637 | $20,620,621 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
72,623 | $12,239,880 | |
| 5 | VTRS |
Viatris Inc
This page
|
505,084 | $8,020,733 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
285,889 | $7,035,728 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
38,087 | $4,225,371 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
140,778 | $2,436,867 |
All Filings in VTRS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,020,733 | 505,084 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $7,070,904 | 523,383 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $6,500,929 | 522,163 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $7,992,458 | 807,319 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $7,229,736 | 809,601 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $15,451,836 | 1,774,034 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $16,367,019 | 1,314,620 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $14,990,715 | 1,291,190 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $13,681,447 | 1,287,060 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $13,576,269 | 1,137,041 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $10,293,070 | 950,422 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $9,170,924 | 930,114 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $8,768,527 | 878,610 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $7,677,471 | 798,074 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $7,636,226 | 686,094 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $6,901,208 | 810,001 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $7,404,666 | 707,227 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $7,567,159 | 695,511 | Shares | Sole | 2022-05-12 | |
| 2021-09-30 | $9,496,097 | 700,819 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $9,852,969 | 689,501 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $14,112,242 | 1,010,182 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $37,031,061 | 1,976,044 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||